Bristol Myers Squibb

Neuropsychiatric conditions are inherently complex and represent some of the greatest challenges of our time, but we are committed to advancing research with the goal of making an impact for patients, caregivers, families and healthcare systems. This #MentalHealthAwarenessMonth, our focus is on building a workplace culture of empathy, creating space for connection and continuing neuroscience research to better support patients, families and caregivers. Our commitment doesn't stop at awareness. It drives the science, the culture and the care that helps people move forward. Learn more about our research in neuroscience here: https://bit.ly/3QIhX9s #Neuroscience #OneBMS

Bonne Journée nationale des médecins! Aujourd'hui, #BMSCanada est fière de rendre hommage aux médecins qui honorent la vocation de la médecine, pour leur leadership, leur expertise clinique et leur dévouement à l'amélioration des soins aux patient(e)s 🩺. Grâce à une prise de décision éclairée et à la collaboration au sein du système de santé, les médecins contribuent à de meilleurs résultats pour les patient(e)s. Nous sommes reconnaissants de l'impact véritablement remarquable de votre travail. #JournéeNationaleDesMédecins #FaireAvancerLaSanté #HonorerLaVocation

We're thrilled to share that our head of Product Development, Manisha Desai, is a 2026 Ascend A-List Award honoree – in recognition of her 25+ years advancing breakthrough therapies for patients and her unwavering commitment to mentoring Pan-Asian leaders. Join us in celebrating Manisha and learn more about the honor: https://bit.ly/3QHFRSp #OneBMS

Today we shared our Q1 earnings results, which reflect continued momentum and execution across the business. Our Growth Portfolio delivered another strong quarter driven by contributions from a broad range of differentiated medicines that are early in their lifecycles. We also made meaningful progress across our pipeline, where we achieved important clinical and regulatory milestones. With the cadence of pivotal readouts expected to increase as the year progresses, we are focused on delivering in the near-term while positioning the company for long-term, sustainable growth. Read more, including important cautionary statements about forward-looking information, here: https://bit.ly/4cR1FUt

Join us in honoring the 10th anniversary of Cultivating Leadership, Innovation & Multigenerational Belonging (CLIMB), whose 5,000 members across 40 countries and 50 chapters bridge the gap between generations and addresses climate concerns, health disparities and mental health. “As we CLIMB together, we celebrate a decade of empowering our community, strengthening support across generations and advancing care for patients,” said Jennifer F. Rasing, Inclusion and Community Impact lead. See how CLIMB’s efforts have contributed to building a brighter future across environmental sustainability, social impact and ethical governance in our 2025 Impact Report: https://bit.ly/4sZklG9 #OneBMS

During our annual Take Your Child to Work Day, future STEM leaders experimented with vinegar and baking soda in the lab, solved math puzzles (and balanced budgets) in an escape room–style challenge, built robots, explored the foundations of biomedical research in a microscopy class and dove into ice cream with our Chief People Officer Amanda Poole. From problem-solving to brainstorming bright ideas, the occasion was a fun reminder of who we’re building the future for. #OneBMS

Human genetics have played a powerful role in advancing medicine, and it's at the heart of how we approach drug discovery. In a recent episode of the Therapeutic Momentum Podcast, Chief Research Officer Robert Plenge shares how insights from genetics guide our work — from identifying targets to designing therapies that meaningfully improve patients’ lives. Listen to the full podcast to hear more about the link between DNA and innovation: https://apple.co/48nbbfg #DNADay #OneBMS

We’re excited to share that Tania Small, MD, has been recognized as the American Cancer Society’s 2026 Humanitarian Award Honoree for embodying the true spirit of service through her leadership, compassion and deep commitment to community. Tania’s drive to treat the whole patient — beyond the bedside — is palpable and reflected in the countless lives she touches. This recognition is a strong testament to how she leads: with purpose, heart and patients always first.

In drug discovery, you don’t always see the whole board. Sometimes you have to play the hand you’re dealt.   In his latest article, Robert Plenge shares how our teams use early data and innovative tools to navigate the Critical Value Creation Period and move forward programs with a higher probability of delivering winning hands to patients: https://lnkd.in/e3i24pKx #OneBMS

🌍 Increasing access to our medicines. Bringing patient insights into study design. A new pledge to protect the water we all share. This Earth Day, our latest Impact Report underscores our commitment to building a better future for patients, people and our planet. A few highlights: → Access to medicines — Our ASPIRE initiative reached 139K+ patients in low- and middle-income countries in 2025. → Patient-centered R&D — 72% of completed protocol reviews through our Patient Expert Engagement Resource program led to meaningful changes to study design driven directly by feedback from patient advocacy groups. → Environmental stewardship — We've set a new goal to reduce freshwater withdrawal by 20% by 2033. These efforts reflect our commitment to making medical science more accessible to the people who need it most — and there's still more work ahead. 🔗 Read the 2025 Impact Report: https://bit.ly/48dZck2 #BuildingABetterFuture #ImpactReport #OneBMS